Eye-Sync
K202927 is the FDA 510(k) clearance record for EYE-SYNC, a class II device, cleared for Syncthink, Inc. on under FDA product code QEA (Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid). FDA's definition for product code QEA reads: "A traumatic brain injury eye movement assessment aid is a prescription device that uses a patient’s tracked eye movements to provide an interpretation of the functional condition of the patient’s brain. This device is an assessment aid...". FDA records list 2 510(k) clearances for Syncthink, Inc., from to . As of , FDA records show one recall naming K202927.
Clearance record
- Decision date
- Received
- (368 days to decision)
- Product code
- QEA Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid
- Regulation
- 21 CFR 882.1455
- Device class
- Class II
- Review panel
- Neurology
- Applicant
- Syncthink, Inc. 2172 Staunton Ct., Palo Alto CA
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code QEA
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 1 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
